 | • レポートコード：GIR-23F3744 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Animal-derived Immune Globulin Products Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の動物由来免疫グロブリン製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 動物由来免疫グロブリン製品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・IVIg液体、IVIgパウダー アプリケーション別セグメントは次のように区分されます。 ・免疫不全、自己免疫疾患、急性感染症 世界の動物由来免疫グロブリン製品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 動物由来免疫グロブリン製品の概要 - タイプ別分析（2017年vs2021年vs2028年）：IVIg液体、IVIgパウダー - アプリケーション別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症 - 世界の動物由来免疫グロブリン製品市場規模・予測 - 世界の動物由来免疫グロブリン製品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：IVIg液体、IVIgパウダー ・アプリケーション別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症 ・動物由来免疫グロブリン製品の北米市場分析 - 動物由来免疫グロブリン製品の北米市場：タイプ別市場規模2017年-2028年 - 動物由来免疫グロブリン製品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・動物由来免疫グロブリン製品のヨーロッパ市場分析 - ：動物由来免疫グロブリン製品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：動物由来免疫グロブリン製品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・動物由来免疫グロブリン製品のアジア太平洋市場分析 - 動物由来免疫グロブリン製品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 動物由来免疫グロブリン製品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・動物由来免疫グロブリン製品の南米市場分析 - 動物由来免疫グロブリン製品の南米市場：タイプ別市場規模2017年-2028年 - 動物由来免疫グロブリン製品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・動物由来免疫グロブリン製品の中東・アフリカ市場分析 - 動物由来免疫グロブリン製品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 動物由来免疫グロブリン製品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Animal-derived Immune Globulin Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Animal-derived Immune Globulin Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the Animal-derived Immune Globulin Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IVIg Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Instituto Bioclon, Merck & Co, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Animal-derived Immune Globulin Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IVIg Liquid
IVIg Powder
Market segment by Application can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The key market players for global Animal-derived Immune Globulin Products market are listed below:
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal-derived Immune Globulin Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal-derived Immune Globulin Products, with price, sales, revenue and global market share of Animal-derived Immune Globulin Products from 2019 to 2022.
Chapter 3, the Animal-derived Immune Globulin Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal-derived Immune Globulin Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Animal-derived Immune Globulin Products market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal-derived Immune Globulin Products.
Chapter 13, 14, and 15, to describe Animal-derived Immune Globulin Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Animal-derived Immune Globulin Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Animal-derived Immune Globulin Products Market Size & Forecast
1.4.1 Global Animal-derived Immune Globulin Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Animal-derived Immune Globulin Products Sales in Volume (2017-2028)
1.4.3 Global Animal-derived Immune Globulin Products Price (2017-2028)
1.5 Global Animal-derived Immune Globulin Products Production Capacity Analysis
1.5.1 Global Animal-derived Immune Globulin Products Total Production Capacity (2017-2028)
1.5.2 Global Animal-derived Immune Globulin Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal-derived Immune Globulin Products Market Drivers
1.6.2 Animal-derived Immune Globulin Products Market Restraints
1.6.3 Animal-derived Immune Globulin Products Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Animal-derived Immune Globulin Products Product and Services
2.1.4 Pfizer Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Rare Disease Therapeutics
2.2.1 Rare Disease Therapeutics Details
2.2.2 Rare Disease Therapeutics Major Business
2.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product and Services
2.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Instituto Bioclon
2.3.1 Instituto Bioclon Details
2.3.2 Instituto Bioclon Major Business
2.3.3 Instituto Bioclon Animal-derived Immune Globulin Products Product and Services
2.3.4 Instituto Bioclon Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co Animal-derived Immune Globulin Products Product and Services
2.4.4 Merck & Co Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Animal-derived Immune Globulin Products Product and Services
2.5.4 Sanofi Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Protherics
2.6.1 Protherics Details
2.6.2 Protherics Major Business
2.6.3 Protherics Animal-derived Immune Globulin Products Product and Services
2.6.4 Protherics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Genzyme Corporation
2.7.1 Genzyme Corporation Details
2.7.2 Genzyme Corporation Major Business
2.7.3 Genzyme Corporation Animal-derived Immune Globulin Products Product and Services
2.7.4 Genzyme Corporation Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Animal-derived Immune Globulin Products Breakdown Data by Manufacturer
3.1 Global Animal-derived Immune Globulin Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Animal-derived Immune Globulin Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Animal-derived Immune Globulin Products
3.4 Market Concentration Rate
3.4.1 Top 3 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.4.2 Top 6 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.5 Global Animal-derived Immune Globulin Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Animal-derived Immune Globulin Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal-derived Immune Globulin Products Market Size by Region
4.1.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
4.1.2 Global Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
4.2 North America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.3 Europe Animal-derived Immune Globulin Products Revenue (2017-2028)
4.4 Asia-Pacific Animal-derived Immune Globulin Products Revenue (2017-2028)
4.5 South America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.6 Middle East and Africa Animal-derived Immune Globulin Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Animal-derived Immune Globulin Products Sales in Volume by Type (2017-2028)
5.2 Global Animal-derived Immune Globulin Products Revenue by Type (2017-2028)
5.3 Global Animal-derived Immune Globulin Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Animal-derived Immune Globulin Products Sales in Volume by Application (2017-2028)
6.2 Global Animal-derived Immune Globulin Products Revenue by Application (2017-2028)
6.3 Global Animal-derived Immune Globulin Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
7.2 North America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
7.3 North America Animal-derived Immune Globulin Products Market Size by Country
7.3.1 North America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
7.3.2 North America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal-derived Immune Globulin Products Sales by Type (2017-2028)
8.2 Europe Animal-derived Immune Globulin Products Sales by Application (2017-2028)
8.3 Europe Animal-derived Immune Globulin Products Market Size by Country
8.3.1 Europe Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2017-2028)
9.2 Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2017-2028)
9.3 Asia-Pacific Animal-derived Immune Globulin Products Market Size by Region
9.3.1 Asia-Pacific Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
10.2 South America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
10.3 South America Animal-derived Immune Globulin Products Market Size by Country
10.3.1 South America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
10.3.2 South America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2017-2028)
11.2 Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2017-2028)
11.3 Middle East & Africa Animal-derived Immune Globulin Products Market Size by Country
11.3.1 Middle East & Africa Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Animal-derived Immune Globulin Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Animal-derived Immune Globulin Products
12.3 Animal-derived Immune Globulin Products Production Process
12.4 Animal-derived Immune Globulin Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Animal-derived Immune Globulin Products Typical Distributors
13.3 Animal-derived Immune Globulin Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Animal-derived Immune Globulin Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Animal-derived Immune Globulin Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Animal-derived Immune Globulin Products Product and Services
Table 6. Pfizer Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Rare Disease Therapeutics Major Business
Table 9. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product and Services
Table 10. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Instituto Bioclon Basic Information, Manufacturing Base and Competitors
Table 12. Instituto Bioclon Major Business
Table 13. Instituto Bioclon Animal-derived Immune Globulin Products Product and Services
Table 14. Instituto Bioclon Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co Major Business
Table 17. Merck & Co Animal-derived Immune Globulin Products Product and Services
Table 18. Merck & Co Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Animal-derived Immune Globulin Products Product and Services
Table 22. Sanofi Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Protherics Basic Information, Manufacturing Base and Competitors
Table 24. Protherics Major Business
Table 25. Protherics Animal-derived Immune Globulin Products Product and Services
Table 26. Protherics Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 28. Genzyme Corporation Major Business
Table 29. Genzyme Corporation Animal-derived Immune Globulin Products Product and Services
Table 30. Genzyme Corporation Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Animal-derived Immune Globulin Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 32. Global Animal-derived Immune Globulin Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Animal-derived Immune Globulin Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Animal-derived Immune Globulin Products Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and Animal-derived Immune Globulin Products Production Site of Key Manufacturer
Table 36. Animal-derived Immune Globulin Products New Entrant and Capacity Expansion Plans
Table 37. Animal-derived Immune Globulin Products Mergers & Acquisitions in the Past Five Years
Table 38. Global Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 39. Global Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 40. Global Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 43. Global Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 44. Global Animal-derived Immune Globulin Products Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Animal-derived Immune Globulin Products Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Animal-derived Immune Globulin Products Price by Type (2017-2022) & (USD/Kg)
Table 47. Global Animal-derived Immune Globulin Products Price by Type (2023-2028) & (USD/Kg)
Table 48. Global Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 49. Global Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 50. Global Animal-derived Immune Globulin Products Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Animal-derived Immune Globulin Products Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Animal-derived Immune Globulin Products Price by Application (2017-2022) & (USD/Kg)
Table 53. Global Animal-derived Immune Globulin Products Price by Application (2023-2028) & (USD/Kg)
Table 54. North America Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 55. North America Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 56. North America Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 59. North America Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 60. North America Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 61. North America Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 62. Europe Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 63. Europe Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 64. Europe Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 67. Europe Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 68. Europe Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 69. Europe Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 70. Asia-Pacific Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 71. Asia-Pacific Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 72. Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 75. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 76. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 77. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 78. South America Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 79. South America Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 80. South America Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 83. South America Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 84. South America Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 85. South America Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 86. Middle East & Africa Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 87. Middle East & Africa Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 88. Middle East & Africa Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 91. Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 92. Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 93. Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 94. Animal-derived Immune Globulin Products Raw Material
Table 95. Key Manufacturers of Animal-derived Immune Globulin Products Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Animal-derived Immune Globulin Products Typical Distributors
Table 99. Animal-derived Immune Globulin Products Typical Customers
List of Figures
Figure 1. Animal-derived Immune Globulin Products Picture
Figure 2. Global Animal-derived Immune Globulin Products Revenue Market Share by Type in 2021
Figure 3. IVIg Liquid
Figure 4. IVIg Powder
Figure 5. Global Animal-derived Immune Globulin Products Revenue Market Share by Application in 2021
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Animal-derived Immune Globulin Products Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Animal-derived Immune Globulin Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Animal-derived Immune Globulin Products Sales (2017-2028) & (MT)
Figure 12. Global Animal-derived Immune Globulin Products Price (2017-2028) & (USD/Kg)
Figure 13. Global Animal-derived Immune Globulin Products Production Capacity (2017-2028) & (MT)
Figure 14. Global Animal-derived Immune Globulin Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Animal-derived Immune Globulin Products Market Drivers
Figure 16. Animal-derived Immune Globulin Products Market Restraints
Figure 17. Animal-derived Immune Globulin Products Market Trends
Figure 18. Global Animal-derived Immune Globulin Products Sales Market Share by Manufacturer in 2021
Figure 19. Global Animal-derived Immune Globulin Products Revenue Market Share by Manufacturer in 2021
Figure 20. Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Animal-derived Immune Globulin Products Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Animal-derived Immune Globulin Products Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 24. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 25. North America Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 26. Europe Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 28. South America Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 30. Global Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 31. Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2017-2028)
Figure 32. Global Animal-derived Immune Globulin Products Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 34. Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2017-2028)
Figure 35. Global Animal-derived Immune Globulin Products Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 37. North America Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 38. North America Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 39. North America Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 40. United States Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 44. Europe Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 45. Europe Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 46. Europe Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 47. Germany Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 56. China Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 63. South America Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 64. South America Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 65. South America Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin Products in 2021
Figure 77. Manufacturing Process Analysis of Animal-derived Immune Globulin Products
Figure 78. Animal-derived Immune Globulin Products Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
• 日本語訳：動物由来免疫グロブリン製品のグローバル市場2022年
• レポートコード：GIR-23F3744 ▷ お問い合わせ（見積依頼・ご注文・質問）